venetoclax,ibrutinib
abbvie,janssen,roche
['ibru', 'captivate', 'venetoclax', 'leukemia', 'janssen']
#janssen #pharmaceuticals announced the phase 2 captivate study, demonstrating the efficacy of #imbruvica (ibrutinib) plus #venetoclax (i+v) in patients with untreated chronic lymphocytic #leukemia #pharma #healthcare #news #eha2022 #eha22 #cancer
iPharmaCenter is a #website which covers #pharmaceutical and #healthcare #news plus #blogs #diseases #drugs #healthcaresystems #globalhealth #pharma